Screening for high uric acid in people with fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests whether people with a type of fatty liver disease called MAFLD also have high uric acid levels, which can affect your health. The goal is to see if your fatty liver is linked to uric acid problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older.
- You have been told you have fatty liver disease, confirmed by an ultrasound or other scan.
- You are not pregnant.
- You do not have cancer or a history of cancer.
- You do not have type 1 diabetes.
- You have not had weight-loss surgery (bariatric surgery) for fatty liver disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether high uric acid levels are linked to liver scarring (fibrosis) in obese people. It may help find new ways to detect or treat liver problems early.
This trial is looking for patients with chronic conditions like diabetes, high blood pressure, obesity, kidney disease, or heart disease to screen for high uric acid levels. It aims to understand how common this is and find better ways to manage it.
This trial is testing a new ultrasound method to measure fat in the liver for people with metabolic fatty liver disease (MAFLD). It may help understand how well ultrasound can show liver fat compared to a liver biopsy or MRI.
This study looks at people who are metabolically healthy but overweight or obese, and how that affects their risk of developing fatty liver disease (MASLD) or high uric acid levels (hyperuricemia). It aims to see if 'healthy' obesity still carries hidden health risks.
This study looks at a new way to check how well your body handles sugar (glucose disposal rate) to detect fatty liver linked to metabolic syndrome. It may help doctors diagnose this condition more easily.
This study classifies fatty liver disease (MAFLD) by examining liver tissue samples. It aims to better understand how metabolic risk factors like high blood sugar, high blood pressure, or excess weight relate to the liver's condition.
Hear when a new Hyperuricemia and MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.